BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Department of Medicine - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/medicine
X-WR-CALDESC:Events for Department of Medicine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240125T120000
DTEND;TZID=America/New_York:20240125T130000
DTSTAMP:20260415T064301
CREATED:20240123T150403Z
LAST-MODIFIED:20240123T150403Z
UID:10001509-1706184000-1706187600@www.med.unc.edu
SUMMARY:Medicine Grand Rounds- Dr. Kevan Herold presents: Finding\, Preventing\, and Reversing Type 1 Diabetes
DESCRIPTION:My background and research are in translational immunology. I am interested in understanding the basis for autoimmune diseases and developing new therapies based on our understanding of disease mechanisms. My focus has largely been in the field of autoimmune Type 1 diabetes. The work encompasses basic laboratory work as well as clinical studies to understand the regulation of autoreactive T cells to clinical trials that involve novel therapeutics. As part of these studies\, my lab has been very interested in the analysis of beta cell function in Type 1 diabetes and identifying the cellular mechanisms that can protect them from immune killing. We have also been studying the development of autoimmune diabetes in patients with cancers who are treated with checkpoint inhibitors. Our clinical and basic studies are focused on understanding how beta cells are destroyed and react to inflammation. Finally\, with the COVID-19 pandemic\, we have been studying the immunologic basis for responses in children and adults who are hospitalized with COVID-19 to understand the mechanisms that can lead to disease protection.
URL:https://www.med.unc.edu/medicine/event/medicine-grand-rounds-dr-kevan-herold-presents-finding-preventing-and-reversing-type-1-diabetes/
LOCATION:Room 4008 Old Clinic Auditorium\, Chapel Hill\, NC\, United States
CATEGORIES:Medicine Grand Rounds
END:VEVENT
END:VCALENDAR